Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
Anticancer Research|May 1, 1995
Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancerG Sliutz, C Tempfer, C Kainz, et al.Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[CD44 splice variants as prognostic factors in invasive cervix carcinoma]A Reinthaller, C Kainz, P Kohlberger, et al.British Journal of Cancer|October 29, 1998
CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseasesC Tempfer, L Hefler, H Heinzl, et al.European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Prognostic value of CD44 splice variants in human stage III cervical cancerC Kainz, P Kohlberger, C Tempfer, et al.International Journal of Cancer|June 21, 1996
Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancerC Kainz, C Tempfer, P Kohlberger, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 15, 2000
Tumor anemia and thrombocytosis in patients with vulvar cancerL Hefler, K Mayerhofer, B Leibman, et al.International Journal of Cancer|June 30, 1998
Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patientsC Tempfer, L Hefler, G Haeusler, et al.Anticancer Research|January 29, 2000
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancerP L Moser, D G Kieback, L Hefler, et al.Anticancer Research|September 1, 1994
Vascular space invasion and inflammatory stromal reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIBC Kainz, G Gitsch, C Tempfer, et al.European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Serum M3/M21 in cervical cancer patientsG Sliutz, C Tempfer, E Hanzal, et al.Pageof 9